Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs. - Wikidata - wikimedia - TriplyDB

Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs.

Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs.

http://www.wikidata.org/entity/Q37728933

about

(-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis.Irisin Induces Angiogenesis in Human Umbilical Vein Endothelial Cells In Vitro and in Zebrafish Embryos In Vivo via Activation of the ERK Signaling Pathway.Cannabidiol inhibits angiogenesis by multiple mechanisms.Paris Saponin II suppresses the growth of human ovarian cancer xenografts via modulating VEGF-mediated angiogenesis and tumor cell migration.miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2.Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2.Hypoxia induces miR-153 through the IRE1α-XBP1 pathway to fine tune the HIF1α/VEGFA axis in breast cancer angiogenesis.

P2860

Q35582270-77301D64-25EA-40C8-867A-D26A450BE8CD Q35737422-B96D3720-D25B-4914-8B31-B64F9D60A472 Q36419293-11FF56F7-A90A-4646-B620-AE07F9885B0A Q39014534-95A922E4-973C-432E-9346-668D824F4BB3 Q39028436-AE97D678-C12A-4431-8657-899ADD4CEFE0 Q39264604-5D8CBC32-8A40-4FEA-A10B-62E31E1F52ED Q49723834-297025A4-A66B-48BE-B709-7AA12783BA3C

P2860

Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs.

http://www.wikidata.org/entity/Q37728933

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 April 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Functional genomics of endothe ...... enic or angiopreventive drugs.

@en

Functional genomics of endothe ...... enic or angiopreventive drugs.

@nl

type

label

Functional genomics of endothe ...... enic or angiopreventive drugs.

@en

Functional genomics of endothe ...... enic or angiopreventive drugs.

@nl

prefLabel

Functional genomics of endothe ...... enic or angiopreventive drugs.

@en

Functional genomics of endothe ...... enic or angiopreventive drugs.

@nl

P1433

Q37728933-313C26CC-A4FE-43AC-B984-4C3BFC6FB9E2

P1476

Q37728933-C9E3227F-3C16-4C4B-A1CF-8DD903C36056

P2860

Q37728933-069D8111-4806-4D34-89EB-00BAF3050523

Q37728933-1476490E-B3AF-4AE5-852B-B3A3C73DC003

Q37728933-1799701D-535B-4F29-96C4-037438A2279F

Q37728933-23390A86-97E5-487A-AD48-0677C91D7A76

Q37728933-2D59AFAF-E6B2-4A4A-9371-DF5BF122C1E5

Q37728933-3A0D2146-4039-4660-90D0-AF9EF2AD02EF

Q37728933-4BB8F4E2-4E93-479E-AB25-25CAB6815D76

Q37728933-82F200D1-368B-441A-8FC1-E1DD1C345494

Q37728933-8AB0EEC1-20BB-4C3C-B5FB-3E4B7CB3F3F4

Q37728933-954502FE-29E1-4ED1-8DE0-E9E924237F8F

P2888

Q37728933-70426BC9-D271-4D30-9CA6-773B436E64F6

P304

Q37728933-58F00B7B-E3A4-4453-A03F-E3A52303E8F0

P31

Q37728933-5722C6FC-09E4-4F6C-B444-31C8F39F3D12

P356

Q37728933-1179C87B-8339-49BC-9837-38AFFAE77874

P433

Q37728933-B347B15D-E9B3-4257-AEDD-4AD01C1BC1BC

P478

Q37728933-2E171B91-8626-42E7-A56D-9C5F5773B478

P50

Q37728933-36BBEEA4-92C4-4123-AA0E-EE53871CDE75

Q37728933-38D9F0F1-ABD7-4090-914D-B720DA12C847

Q37728933-64B73F96-EEEE-4586-BA24-D5D08FA3E7EB

Q37728933-E10B8EFA-866A-4C7F-AB16-0E4CA782D1C3

P577

Q37728933-B81693D4-F0B0-4409-BD44-7D52B5FCCA11

P698

Q37728933-D892E700-FE69-416C-90C7-CE3D0314A631

P921

Q37728933-3477E98A-AD4D-40A5-9110-DBC57E2C5057

P356

S10585-010-9312-5

P1433

Clinical & Experimental Metastasis

P1476

Functional genomics of endothe ...... enic or angiopreventive drugs.

@en

P2860

Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA

Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases

Inhibitory actions of genistein in human breast cancer (MCF-7) cells

Genome-wide analysis of molecular changes in IL-12-induced control of mammary carcinoma via IFN-gamma-independent mechanisms

Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts.

Interferon (IFN)-beta gene transfer into TS/A adenocarcinoma cells and comparison with IFN-alpha: differential effects on tumorigenicity and host response

Identification of genes selectively regulated by IFNs in endothelial cells.

Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in mice

IL-18 gene expression pattern in exogenously treated AML cells.

Alterations of metastasis-related genes identified using an oligonucleotide microarray of genistein-treated HCC1395 breast cancer cells.

P2888

s10585-010-9312-5

P304

419-439

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10585-010-9312-5

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Douglas M. Noonan

Stefano Indraccolo

P577

2010-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20383568

http://www.w3.org/2001/XMLSchema#string

P921